Lost Money on Myriad Genetics, Inc. (MYGN)? You May Have Been Affected by Fraud - Contact Levi & KorsinskyAccesswire • 11/06/24
Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Investors to Inquire about Securities InvestigationAccesswire • 11/06/24
MYGN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Myriad Genetics, Inc.Accesswire • 11/06/24
Lost Money on Myriad Genetics, Inc.(MYGN)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyAccesswire • 11/05/24
Myriad Genetics, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - MYGNAccesswire • 11/04/24
Myriad Genetics Comments on UnitedHealthcare's Updated Medical Policy for Pharmacogenetic TestingGlobeNewsWire • 11/04/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myriad Genetics, Inc. - MYGNAccesswire • 11/01/24
Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024GlobeNewsWire • 10/30/24
Myriad Genetics (MYGN) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 10/28/24
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record IntegrationGlobeNewsWire • 10/15/24
MYGN Taps Ultima Genomics' UG 100 Platform for Advanced Clinical TestsZacks Investment Research • 10/11/24
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast CancerGlobeNewsWire • 10/08/24
Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive GenomicsGlobeNewsWire • 10/03/24
Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority DateGlobeNewsWire • 10/01/24
Myriad Genetics to Participate in Two Upcoming Investor Healthcare ConferencesGlobeNewsWire • 08/21/24
Myriad (MYGN) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/07/24
Myriad Genetics (MYGN) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/06/24
EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICSGlobeNewsWire • 08/02/24